OA
BLUE

Omega Advisors’s bluebird bio BLUE Stock Holding History

Omega Advisors’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,860
Closed -$5.25M – 86
2017
Q2 		$5.25M Buy
+3,860
New +$4.66M 0.22% 61
2017
Q1 		– Sell
-3,860
Closed -$3.08M – 85
2016
Q4 		$3.08M Buy
+3,860
New +$3.07M 0.14% 52
2015
Q3 		– Sell
-1,852
Closed -$4.04M – 85
2015
Q2 		$4.04M Buy
+1,852
New +$3.77M 0.06% 87
2015
Q1 		– Sell
-1,930
Closed -$2.29M – 101
2014
Q4 		$2.29M Sell
1,930
-1,050
-35% -$702K 0.04% 76
2014
Q3 		$1.39M Buy
+2,980
New +$1.38M 0.02% 83

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Omega Advisors's BLUE Position: Q3 2017 in Review

Omega Advisors sold out of bluebird bio (BLUE) in Q3 2017, closing a stake of 3,860 shares — an estimated $5.25M sold.

Omega Advisors first reported a position in BLUE in Q3 2014 and held it in 5 quarters. The position peaked at $5.25M in Q2 2017. 243 funds tracked by Wall St. Rank hold BLUE as of Q3 2017.

  • Omega Advisors reported no remaining bluebird bio position as of Q3 2017 after selling out during the quarter.
  • Omega Advisors sold 3,860 bluebird bio shares in Q3 2017, an estimated $5.25M.
  • Omega Advisors first reported a position in bluebird bio in Q3 2014 and held it in 5 quarters.
  • Omega Advisors's bluebird bio position peaked at $5.25M in Q2 2017.
  • 243 funds tracked by Wall St. Rank held bluebird bio as of Q3 2017.

Based on Omega Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.